Literature DB >> 28182596

The Dawn of Transparency: Insights from the Physician Payment Sunshine Act in Plastic Surgery.

Rizwan Ahmed1, Joseph Lopez, Sunjae Bae, Allan B Massie, Eric K Chow, Karan Chopra, Babak J Orandi, Bonnie E Lonze, James W May, Justin M Sacks, Dorry L Segev.   

Abstract

BACKGROUND: The Physician Payments Sunshine Act (PSSA) is a government initiative that requires all biomedical companies to publicly disclose payments to physicians through the Open Payments Program (OPP). The goal of this study was to use the OPP database and evaluate all nonresearch-related financial transactions between plastic surgeons and biomedical companies.
METHODS: Using the first wave of OPP data published on September 30, 2014, we studied the national distribution of industry payments made to plastic surgeons during a 5-month period. We explored whether a plastic surgeon's scientific productivity (as determined by their h-index), practice setting (private versus academic), geographic location, and subspecialty were associated with payment amount.
RESULTS: Plastic surgeons (N = 4195) received a total of US $5,278,613. The median (IQR) payment to a plastic surgeon was US $115 (US $35-298); mean, US $158. The largest payment to an individual was US $341,384. The largest payment category was non-CEP speaker fees (US $1,709,930) followed by consulting fees (US $1,403,770). Plastic surgeons in private practice received higher payments per surgeon compared with surgeons in academic practice (median [IQR], US $165 [US $81-$441] vs median [IQR], US $112 [US $33-$291], rank-sum P < 0.001). Among academic plastic surgeons, a higher h-index was associated with 77% greater chance of receiving at least US $1000 in total payments (RR/10 unit h-index increase = 1.47 1.772.11, P < 0.001). This association was not seen among plastic surgeons in private practice (RR = 0.89 1.091.32, P < 0.4).
CONCLUSIONS: Plastic surgeons in private practice receive higher payments from industry. Among academic plastic surgeons, higher payments were associated with higher h-indices.

Entities:  

Mesh:

Year:  2017        PMID: 28182596      PMCID: PMC5308560          DOI: 10.1097/SAP.0000000000000874

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  34 in total

1.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

2.  Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.

Authors:  Mohit Bhandari; Jason W Busse; Dianne Jackowski; Victor M Montori; Holger Schünemann; Sheila Sprague; Derek Mears; Emil H Schemitsch; Dianne Heels-Ansdell; P J Devereaux
Journal:  CMAJ       Date:  2004-02-17       Impact factor: 8.262

3.  Association of industry sponsorship to published outcomes in gastrointestinal clinical research.

Authors:  Alphonso Brown; Daniel Kraft; Sara M Schmitz; Virginia Sharpless; Christopher Martin; Ritesh Shah; Nicholas J Shaheen
Journal:  Clin Gastroenterol Hepatol       Date:  2006-11-13       Impact factor: 11.382

4.  Health industry practices that create conflicts of interest: a policy proposal for academic medical centers.

Authors:  Troyen A Brennan; David J Rothman; Linda Blank; David Blumenthal; Susan C Chimonas; Jordan J Cohen; Janlori Goldman; Jerome P Kassirer; Harry Kimball; James Naughton; Neil Smelser
Journal:  JAMA       Date:  2006-01-25       Impact factor: 56.272

5.  Sunlight as disinfectant--new rules on disclosure of industry payments to physicians.

Authors:  Meredith B Rosenthal; Michelle M Mello
Journal:  N Engl J Med       Date:  2013-05-30       Impact factor: 91.245

6.  Effective communication of standard errors and confidence intervals.

Authors:  Thomas A Louis; Scott L Zeger
Journal:  Biostatistics       Date:  2008-06-10       Impact factor: 5.899

7.  Orthopaedic surgeons and the medical device industry: the threat to scientific integrity and the public trust.

Authors:  Richard H Gelberman; David Samson; Sohail K Mirza; John J Callaghan; Vincent D Pellegrini
Journal:  J Bone Joint Surg Am       Date:  2010-03       Impact factor: 5.284

8.  Doctors, drug companies, and gifts.

Authors:  M M Chren; C S Landefeld; T H Murray
Journal:  JAMA       Date:  1989 Dec 22-29       Impact factor: 56.272

9.  Looking a gift horse in the mouth: corporate gifts supporting life sciences research.

Authors:  E G Campbell; K S Louis; D Blumenthal
Journal:  JAMA       Date:  1998-04-01       Impact factor: 56.272

10.  The surgeon as a consultant for medical device manufacturers: what do our patients think?

Authors:  Mustafa H Khan; Joon Y Lee; Jeffrey A Rihn; Ezequiel H Cassinelli; Moe R Lim; James D Kang; William F Donaldson
Journal:  Spine (Phila Pa 1976)       Date:  2007-11-01       Impact factor: 3.468

View more
  6 in total

1.  Industry Payments to Plastic Surgeons: What Has Changed Over the Last 6 Years Following Implementation of the Physician Payments Sunshine Act?

Authors:  Rowland W Pettit; Jordan Kaplan; Matthew M Delancy; Edward Reece; Sebastian Winocour; Anaeze C Offodile; Anand Kumar; Carrie K Chu
Journal:  Aesthet Surg J       Date:  2022-01-12       Impact factor: 4.485

2.  The Sun Is Still Shining: Nature of Industry Payments to Transplant Surgeons From 2014 to 2019.

Authors:  Conner V Lombardi; Jacob J Lang; Deklin Clayton; Puneet Sindhwani; Michael Rees; Obi Ekwenna
Journal:  Transplant Direct       Date:  2022-04-21

3.  Characteristics of Industry Payments to Ophthalmologists in the Open Payments Database.

Authors:  Dane H Slentz; Christine C Nelson; Paul R Lichter
Journal:  JAMA Ophthalmol       Date:  2019-07-03       Impact factor: 7.389

4.  Pushing the Needle of Entrepreneurship and Innovation: Where Do Plastic and Reconstructive Surgeons Stand?

Authors:  Sumun Khetpal; Alvaro Reátegui; Joseph Lopez; Justin M Sacks; Adnan Prsic
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-04-28

5.  Plastic Surgeons' Perceptions of Financial Conflicts of Interest and the Sunshine Act.

Authors:  Taylor E Purvis; Joseph Lopez; Jacqueline Milton; James W May; Amir H Dorafshar
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-04-04

Review 6.  Assessment of Pharmaceutical Company and Device Manufacturer Payments to Gastroenterologists and Their Participation in Clinical Practice Guideline Panels.

Authors:  Salman Nusrat; Taseen Syed; Sanober Nusrat; Sixia Chen; Wei-Jen Chen; Klaus Bielefeldt
Journal:  JAMA Netw Open       Date:  2018-12-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.